Stock search

Ticker or company name

Steris

STE · NYSE · Health Care

$261,91Down −2,41 (−0,91%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$25,7 bn
Div. yield
1,0%
Year to date
+4,3%
52 weeks: $195,14$269,44

Ratio score

75/100
Ratio would consider buying

based on 8 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 2 — · 1 ✕ · 2 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM31,948,725,1
Forward P/E23,1—16,2
PEG1,6—2,2
P/S4,34,12,2
EV/EBITDA16,618,017,3
P/FCF27,7—19,5
P/B3,63,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 13 analysts

Buy
9
Hold
4
Sell
0

Beat the EPS forecast in 2 of the last 4 quarters

QuarterEstimateActualSurprise
Q2 20272,702,94Up +8,8%
Q1 20272,532,59Up +2,5%
Q4 20262,882,83Down −1,6%
Q3 20262,562,53Down −1,1%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,59 bn1,49 bn1,59 bn1,50 bn1,46 bn1,39 bn1,48 bn1,37 bn1,33 bn1,28 bn1,42 bn1,40 bn
EPS——2,241,961,941,791,471,751,511,46−0,011,42
Margin13,5%13,4%13,9%12,9%13,1%12,8%9,8%12,7%11,3%11,4%−0,1%10,1%
FCF213 m280 m245 m200 m201 m326 m190 m244 m149 m196 m163 m172 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $8,60 m.

NameAmountSharesPrice
burton karen l11 Nov 2026 · sale$1,50 m5 880$255,62
sohi mohsen10 Nov 2026 · sale$422 7441 665$253,90
sohi mohsen10 Nov 2026 · sale$816 2643 228$252,87
sohi mohsen12 Aug 2026 · sale$956 7954 058$235,78
zangerle john adam15 Jun 2026 · sale$296 9681 419$209,28
carestio daniel a5 Jun 2026 · sale$291 2881 374$212,00
carestio daniel a4 Jun 2026 · sale$655 5113 054$214,64
breeden richard c2 Jun 2026 · sale$310 2841 481$209,51
feldmann cynthia l5 Mar 2026 · sale$734 8773 098$237,21
madsen julia21 Nov 2025 · sale$559 6322 136$262,00
madsen julia21 Nov 2025 · sale$752 4642 872$262,00
tamaro renato18 Nov 2025 · sale$386 6401 500$257,76
tamaro renato18 Nov 2025 · sale$54 702212$258,03
tamaro renato18 Nov 2025 · sale$855 6973 324$257,43

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
IE
IPO date
3 Nov 2015

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
RMDResMed$238,1983would consider21,3+9,0%27,8%
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.